Skip to content 
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. more
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | -4.72% | 0.5% |
| 1-Month Return | 15.85% | 3.86% |
| 3-Month Return | 37.19% | 1.92% |
| 6-Month Return | 33.29% | 12.03% |
| 1-Year Return | 110.06% | 18.56% |
| 3-Year Return | 122.93% | 73.83% |
| 5-Year Return | 11.93% | 70.11% |
| 10-Year Return | 148.11% | 252.93% |
| Stock name | Ticker | Weight |
|---|---|---|
 Net Other Assets (Liabilities) | Net.Other.Assets..Liabilities. | 40.65% |
 PROSHARES GENIUS MNY MKT ETF | IQMM | 4.95% |
 AMGEN INC | AMGN | 4.75% |
 VERTEX PHARMACEUTICALS INC | VRTX | 4.48% |
 GILEAD SCIENCES INC | GILD | 4.01% |
 REGENERON PHARMACEUTICALS | REGN | 2.89% |
 MODERNA INC | MRNA | 1.93% |
 REVOLUTION MEDICINES INC | RVMD | 1.56% |
 ILLUMINA INC | ILMN | 1.15% |
 BIOGEN INC | BIIB | 1.14% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 1.12% |
 ARGENX SE - ADR | ARGX | 1% |
 ROYALTY PHARMA PLC- CL A | RPRX | 0.95% |
 INSMED INC | INSM | 0.91% |
 ROIVANT SCIENCES LTD | ROIV | 0.88% |
 INCYTE CORP | INCY | 0.88% |
 UNITED THERAPEUTICS CORP | UTHR | 0.77% |
 GUARDANT HEALTH INC | GH | 0.76% |
 VIATRIS INC | VTRS | 0.67% |
 MEDPACE HOLDINGS INC | MEDP | 0.6% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.55% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.54% |
 ASCENDIS PHARMA A/S | ASND | 0.54% |
 BRIDGEBIO PHARMA INC | BBIO | 0.53% |
 EXELIXIS INC | EXEL | 0.48% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.44% |
 HALOZYME THERAPEUTICS INC | HALO | 0.44% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.44% |
 BEONE MEDICINES LTD-ADR | ONC | 0.43% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.42% |
 BIONTECH SE-ADR | BNTX | 0.42% |
 TEMPUS AI INC-CL A | TEM | 0.39% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.38% |
 SANOFI-ADR | SNY | 0.37% |
 KRYSTAL BIOTECH INC | KRYS | 0.37% |
 AXSOME THERAPEUTICS INC | AXSM | 0.36% |
 IONIS PHARMACEUTICALS INC | IONS | 0.36% |
 CYTOKINETICS INC | CYTK | 0.35% |
 KYMERA THERAPEUTICS INC | KYMR | 0.34% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.34% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% |
 CRINETICS PHARMACEUTICALS IN | CRNX | 0.32% |
 TWIST BIOSCIENCE CORP | TWST | 0.31% |
 VAXCYTE INC | PCVX | 0.31% |
 IMMUNOVANT INC | IMVT | 0.3% |
 IMMUNITYBIO INC | IBRX | 0.3% |
 APOGEE THERAPEUTICS INC | APGE | 0.29% |
 ALKERMES PLC | ALKS | 0.28% |
 SPYRE THERAPEUTICS INC | SYRE | 0.28% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.26% |
 CARIS LIFE SCIENCES INC | CAI | 0.26% |
 10X GENOMICS INC-CLASS A | TXG | 0.25% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.24% |
 ABIVAX SA-ADR | ABVX | 0.23% |
 CG ONCOLOGY INC | CGON | 0.23% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.22% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.21% |
 COGENT BIOSCIENCES INC | COGT | 0.21% |
 PTC THERAPEUTICS INC | PTCT | 0.21% |
 XENON PHARMACEUTICALS INC | XENE | 0.2% |
 LIGAND PHARMACEUTICALS | LGND | 0.2% |
 ERASCA INC | ERAS | 0.2% |
 AMNEAL PHARMACEUTICALS INC | AMRX | 0.2% |
 CRISPR THERAPEUTICS AG | CRSP | 0.2% |
 ORUKA THERAPEUTICS INC | ORKA | 0.19% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.18% |
 EDGEWISE THERAPEUTICS INC | EWTX | 0.16% |
 DEFINIUM THERAPEUTICS INC | DFTX | 0.16% |
 INDIVIOR PHARMACEUTICALS INC | INDV | 0.15% |
 DYNE THERAPEUTICS INC | DYN | 0.15% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.14% |
 RELAY THERAPEUTICS INC | RLAY | 0.14% |
 AMYLYX PHARMACEUTICALS INC | AMLX | 0.14% |
 DENALI THERAPEUTICS INC | DNLI | 0.13% |
 STRUCTURE THERAPEUTICS INC | GPCR | 0.13% |
 KINIKSA PHARMACEUTICALS INTE | KNSA | 0.13% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.13% |
 ENLIVEN THERAPEUTICS INC | ELVN | 0.12% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.12% |
 ABCELLERA BIOLOGICS INC | ABCL | 0.12% |
 VERACYTE INC | VCYT | 0.12% |
 GRAIL INC | GRAL | 0.12% |
 TANGO THERAPEUTICS INC | TNGX | 0.12% |
 TARSUS PHARMACEUTICALS INC | TARS | 0.11% |
 UNIQURE NV | QURE | 0.11% |
 DISC MEDICINE INC | IRON | 0.11% |
 NEWAMSTERDAM PHARMA CO NV | NEWAMSTERDAM.PHARMA.CO.NV | 0.11% |
 BEAM THERAPEUTICS INC | BEAM | 0.11% |
 MBX BIOSCIENCES INC | MBX | 0.11% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.11% |
 ALUMIS INC | ALMS | 0.1% |
 NURIX THERAPEUTICS INC | NRIX | 0.1% |
 ATAIBECKLEY INC | ATAI | 0.09% |
 SUPERNUS PHARMACEUTICALS INC | SUPN | 0.09% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.09% |
 GENMAB A/S -SP ADR | GMAB | 0.09% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.09% |
 PRECIGEN INC | PGEN | 0.09% |
 PHARVARIS NV | PHVS | 0.09% |
 VERA THERAPEUTICS INC | VERA | 0.09% |
 TREVI THERAPEUTICS INC | TRVI | 0.08% |
 KODIAK SCIENCES INC | KOD | 0.08% |
 RAPPORT THERAPEUTICS INC | RAPP | 0.08% |
 HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.08% |
 OCULAR THERAPEUTIX INC | OCUL | 0.08% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.08% |
 ADMA BIOLOGICS INC | ADMA | 0.08% |
 UROGEN PHARMA LTD | URGN | 0.08% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.07% |
 AURINIA PHARMACEUTICALS INC | AUPH | 0.07% |
 VERICEL CORP | VCEL | 0.07% |
 NOVOCURE LTD | NVCR | 0.07% |
 ZYMEWORKS INC | ZYME | 0.07% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.07% |
 ZENAS BIOPHARMA INC | ZBIO | 0.07% |
 STOKE THERAPEUTICS INC | STOK | 0.07% |
 XENCOR INC | XNCR | 0.07% |
 GH RESEARCH PLC | GHRS | 0.07% |
 COMPASS PATHWAYS PLC | CMPS | 0.06% |
 VIR BIOTECHNOLOGY INC | VIR | 0.06% |
 INHIBRX BIOSCIENCES INC | INBX | 0.06% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.06% |
 PERSONALIS INC | PSNL | 0.06% |
 FORTREA HOLDINGS INC | FTRE | 0.06% |
 SEPTERNA INC | SEPN | 0.06% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.06% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.06% |
 LEGEND BIOTECH CORP-ADR | LEGN | 0.06% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.06% |
 ANI PHARMACEUTICALS INC | ANIP | 0.06% |
 ANAPTYSBIO INC | ANAB | 0.06% |
 ETON PHARMACEUTICALS INC | ETON | 0.06% |
 IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.06% |
 INNOVIVA INC | INVA | 0.05% |
 ALVOTECH SA | ALVO | 0.05% |
 BICARA THERAPEUTICS INC | BCAX | 0.05% |
 NOVAVAX INC | NVAX | 0.05% |
 MAZE THERAPEUTICS INC | MAZE | 0.05% |
 TYRA BIOSCIENCES INC | TYRA | 0.05% |
 XERIS BIOPHARMA HOLDINGS INC | XERS | 0.05% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.05% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.05% |
 HARROW INC | HROW | 0.05% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.05% |
 ABSCI CORP | ABSI | 0.05% |
 OMEROS CORP | OMER | 0.05% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.05% |
 REPLIMUNE GROUP INC | REPL | 0.05% |
 MEIRAGTX HOLDINGS PLC | MGTX | 0.05% |
 VOR BIOPHARMA INC | VOR | 0.04% |
 MANNKIND CORP | MNKD | 0.04% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.04% |
 MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.04% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.04% |
 KURA ONCOLOGY INC | KURA | 0.04% |
 JANUX THERAPEUTICS INC | JANX | 0.04% |
 SANA BIOTECHNOLOGY INC | SANA | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 CASTLE BIOSCIENCES INC | CSTL | 0.04% |
 PACIRA BIOSCIENCES INC | PCRX | 0.04% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.04% |
 AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.03% |
 WAVE LIFE SCIENCES INC | WVE | 0.03% |
 GERON CORP | GERN | 0.03% |
 SOLID BIOSCIENCES INC | SLDB | 0.03% |
 CANDEL THERAPEUTICS INC | CADL | 0.03% |
 DESIGN THERAPEUTICS INC | DSGN | 0.03% |
 ARDELYX INC | ARDX | 0.03% |
 GRIFOLS SA-ADR | GRFS | 0.03% |
 MESOBLAST LTD- SPON ADR | MESO | 0.03% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.03% |
 THERAVANCE BIOPHARMA INC | TBPH | 0.03% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.03% |
 ZAI LAB LTD-ADR | ZLAB | 0.03% |
 ACLARIS THERAPEUTICS INC | ACRS | 0.03% |
 COLLEGIUM PHARMACEUTICAL INC | COLL | 0.03% |
 ANNEXON INC | ANNX | 0.03% |
 PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.03% |
 AURA BIOSCIENCES INC | AURA | 0.03% |
 PHATHOM PHARMACEUTICALS INC | PHAT | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.02% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.02% |
 ZEVRA THERAPEUTICS INC | ZVRA | 0.02% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.02% |
 TECTONIC THERAPEUTIC INC | TECX | 0.02% |
 PRIME MEDICINE INC | PRME | 0.02% |
 CORMEDIX INC | CRMD | 0.02% |
 OMNIAB INC | OABI | 0.02% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% |
 AQUESTIVE THERAPEUTICS INC | AQST | 0.02% |
 ALTIMMUNE INC | ALT | 0.02% |
 ARVINAS INC | ARVN | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 EVOLUS INC | EOLS | 0.02% |
 NEUROGENE INC | NGNE | 0.02% |
 CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% |
 KYVERNA THERAPEUTICS INC | KYTX | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 REGENXBIO INC | RGNX | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 EDITAS MEDICINE INC | EDIT | 0.02% |
 KAMADA LTD | KMDA | 0.02% |
 AUTOLUS THERAPEUTICS PLC | AUTL | 0.02% |
 PUMA BIOTECHNOLOGY INC | PBYI | 0.02% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.02% |
 LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.02% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.02% |
 BIOAGE LABS INC | BIOA | 0.02% |
 ATEA PHARMACEUTICALS INC | AVIR | 0.02% |
 C4 THERAPEUTICS INC | CCCC | 0.02% |
 ROCKET PHARMACEUTICALS INC | RCKT | 0.01% |
 LARIMAR THERAPEUTICS INC | LRMR | 0.01% |
 ENANTA PHARMACEUTICALS INC | ENTA | 0.01% |
 ALPHA TEKNOVA INC | TKNO | 0.01% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 EYEPOINT INC | EYPT | 0.01% |
 UPSTREAM BIO INC | UPB | 0.01% |
 FOGHORN THERAPEUTICS INC | FHTX | 0.01% |
 LYELL IMMUNOPHARMA INC | LYEL | 0.01% |
 IMMUNEERING CORP - CLASS A | IMRX | 0.01% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.01% |
 ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% |
 INVIVYD INC | IVVD | 0.01% |
 ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% |
 ENTRADA THERAPEUTICS INC | TRDA | 0.01% |
 AC IMMUNE SA | ACIU | 0.01% |
 SIONNA THERAPEUTICS INC | SION | 0.01% |
 NEUMORA THERAPEUTICS INC | NMRA | 0.01% |
 FULCRUM THERAPEUTICS INC | FULC | 0.01% |
 SIGA TECHNOLOGIES INC | SIGA | 0.01% |
 KEROS THERAPEUTICS INC | KROS | 0.01% |
 COHERUS ONCOLOGY INC | CHRS | 0.01% |
 VOYAGER THERAPEUTICS INC | VYGR | 0.01% |
 PEPGEN INC | PEPG | 0.01% |
 NOVABRIDGE BIOSCIENCES | NBP | 0.01% |
 PYXIS ONCOLOGY INC | PYXS | 0.01% |
 BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% |
 JYONG BIOTECH LTD | MENS | 0.01% |
 LIFECORE BIOMEDICAL INC | LFCR | 0.01% |
 CARIBOU BIOSCIENCES INC | CRBU | 0.01% |
 LENZ THERAPEUTICS INC | LENZ | 0.01% |
 QUANTUM-SI INC | QSI | 0.01% |
 TENAYA THERAPEUTICS INC | TNYA | 0.01% |
 CODEXIS INC | CDXS | 0.01% |
 HUMACYTE INC | HUMA | 0.01% |
 BLACK DIAMOND THERAPEUTICS I | BDTX | 0% |
 AARDVARK THERAPEUTICS INC | AARD | 0% |
 RANI THERAPEUTICS HOLDINGS-A | RANI | 0% |
 GOSSAMER BIO INC | GOSS | 0% |
 CARTESIAN THERAPEUTICS-CVR | CARTESIAN.THERAPEUTICS.CVR | 0% |
 NASDAQ Biotechnology Index SWAP Citibank NA | NASDAQ.Biotechnology.Index.SWAP.Citibank.NA | 0% |
 NASDAQ Bio Index SWAP BNP Paribas | NASDAQ.Bio.Index.SWAP.BNP.Paribas | 0% |
 NASDAQ Biotechnology Index SWAP Societe Generale | NASDAQ.Biotechnology.Index.SWAP.Societe.Generale | 0% |
 THIRD HARMONIC BIO INC | THRD | 0% |
 NASDAQ Biotechnology Index SWAP UBS AG | NASDAQ.Biotechnology.Index.SWAP.UBS.AG | 0% |
 NASDAQ Biotechnology Index SWAP Bank of America NA | NASDAQ.Biotechnology.Index.SWAP.Bank.of.America.NA | 0% |
 NASDAQ Biotechnology Index SWAP Goldman Sachs International | NASDAQ.Biotechnology.Index.SWAP.Goldman.Sachs.International | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ProShares Ultra Nasdaq Biotechnology (BIB) share price today is $114.425.
Yes, Indians can buy shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. To buy BIB from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. You can start investing in ProShares Ultra Nasdaq Biotechnology (BIB) with a minimum investment of $1.
The 52-week high price of ProShares Ultra Nasdaq Biotechnology (BIB) is $126.4. The 52-week low price of ProShares Ultra Nasdaq Biotechnology (BIB) is $55.24.
The stock symbol (or ticker) of ProShares Ultra Nasdaq Biotechnology is BIB.
Yes, you can setup SIP in ProShares Ultra Nasdaq Biotechnology shares. Follow the below steps to create the SIP:
Here is the historical performance of BIB on the Vested app.
The expense ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.95%.
Link copied 
